An Improved Model for Disease Progression in Patients From the Alzheimer's Disease Neuroimaging Initiative

Administration and Scoring Variance on the ADAS-Cog

(2017) Donald J. Connor et al.   JOURNAL OF ALZHEIMERS DISEASE

Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database

(2010) Kaori Ito et al.   Alzheimers & Dementia

Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People

(2010) Geert De Meyer   ARCHIVES OF NEUROLOGY

Differences in Medication Use in the Alzheimerʼs Disease Neuroimaging Initiative

(2010) Noam U. Epstein et al.   DRUGS & AGING

The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts

(2010) S. J. Cano et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease

(2010) R. A. Honea et al.   NEUROLOGY

Serial MRI and CSF biomarkers in normal aging, MCI, and AD

(2010) P. Vemuri et al.   NEUROLOGY

Disease progression meta-analysis model in Alzheimer's disease

(2009) Kaori Ito et al.   Alzheimers & Dementia

Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization

(2009) R. C. Petersen et al.   NEUROLOGY

Assessing Change in Cognitive Function in Dementia: The Relative Utilities of the Alzheimer’s Disease Assessment Scale – Cognitive Subscale and the Cognitive Drug Research System

(2008) Keith A. Wesnes   Neurodegenerative Diseases